Jazz Pharmaceuticals plc (JAZZ) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

SA Transcripts 162.14K Followers Follow Jazz Pharmaceuticals plc ( JAZZ ) Wells Fargo 21st Annual Healthcare Conference September 9, 2026 1:30 PM EDT Company Participants Samantha Pearce - Executive VP & Chief Commercial Officer John Bluth - Head of Investor Relations Conference Call Participants Mohit Bansal - Wells Fargo Securities, LLC, Research Division Presentation Mohit Bansal Wells Fargo Securities, LLC, Research Division Awesome. Thank you for joining us. My name is Mohit Bansal. I'm one of the biotech and pharma analysts here at Wells Fargo. And I'm joined by team Jazz today. Music, please. So I'm joined by Sam Pearce. She's the EVP and Chief Commercial Officer; and John Bluth, the Head IR of the company. Thank you very much for joining us today. Samantha Pearce Executive VP & Chief Commercial Officer Thank you. John Bluth Head of Investor Relations Thank you for having us very much, Mohit. And just a quick word to note that Sam and I will be making some forward-looking statements today. So please do refer to the risk factors in our securities filings. And if we do reference guidance, we're referencing guidance that we updated most recently on our last earnings update in early August and any reference to non-GAAP measures are also reconciled in those recent earnings. Question-and-Answer Session Mohit Bansal Wells Fargo Securities, LLC, Research Division Okay. Awesome. Thank you, John. So Sam, let's just talk about -- like just start with like the great things in the sales and marketing team have achieved in this year. I mean you have raised the guidance last quarter. Talk a little bit about the company, the setup and what do you think is going right with the company right now? Samantha Pearce Executive VP & Chief Commercial Officer Yes. Thank you. Well, I mean, I think I'm, first and foremost, delighted with the way the teams are executing on the